Virus Plus (Deseret Biologicals, Inc.)


Welcome to the PulseAid listing for the Virus Plus drug offered from Deseret Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Deseret Biologicals, Inc.
NON-PROPRIETARY NAME: Influenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode
SUBSTANCE NAME: INFLUENZA A VIRUS; INFLUENZA B VIRUS; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 5; HUMAN HE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-04-18
END MARKETING DATE: 2019-09-24


Virus Plus HUMAN OTC DRUG Details:

Item DescriptionVirus Plus from Deseret Biologicals, Inc.
LABELER NAME: Deseret Biologicals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 12; 15; 15; 15; 15; 18; 18; 33([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2014-04-18
END MARKETING DATE: 2019-09-24
PRODUCT ID: 43742-0397_0ee494e9-6916-45c7-8aaf-77ba35409460
PRODUCT NDC: 43742-0397
APPLICATION NUMBER:

Other INFLUENZA A VIRUS; INFLUENZA B VIRUS; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 5; HUMAN HE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Deseret Biologicals, Inc.Virus Plus